| INDICATIONS AND USAGE
HORIZANT is indicated for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS) in adults.
USE IN SPECIFIC POPULATIONS
DOSAGE AND ADMINISTRATION
If the dose is not taken at the recommended time, the next dose should be taken the following day as prescribed.
Tablets should be swallowed whole and should not be cut, crushed, or chewed.
Renal Impairment and Hemodialysis
In patients with stable renal function, CrCl can be estimated using the equation of Cockcroft and Gault:
for males: CrCl = (140-age)(weight) / [(72)(SCr)]
for females: CrCl = (0.85)(140-age)(weight) / [(72)(SCr)]
where age is in years, weight is in kilograms, and SCr is serum creatinine in mg/dL.
HORIZANT is not recommended for use in patients with a CrCl <30 mL/min or on hemodialysis because the dose cannot be reduced below 600 mg.
NDC 0173-0806-01: Bottles of 30
National Institutes of Health, U.S. National Library of Medicine, DailyMed Database.
Provides access to the latest drug monographs submitted to the Food and Drug Administration (FDA). Please review the latest applicable package insert for additional information and possible updates. A local search option of this data can be found here.
The authors make no claims of the accuracy of the information contained herein; and these suggested doses are not a substitute for clinical judgment. Neither GlobalRPh Inc. nor any other party involved in the preparation of this program shall be liable for any special, consequential, or exemplary damages resulting in whole or part from any user’s use of or reliance upon this material.PLEASE READ THE DISCLAIMER CAREFULLY BEFORE ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU AGREE TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER. Read the disclaimer